The effect of azoximer bromide (Polyoxidonium(®)) in patients hospitalized with coronavirus disease (COVID-19): an open-label, multicentre, interventional clinical study

por Efimov, Sergey V, Matsiyeuskaya, Natallia V, Boytsova, Olga V, Akhieva, Lyudmila Yu, Kvasova, Elena I, Harrison, Francisco, Karpova, Yulia S, Tikhonov, Anton, Khomyakova, Nadezhda F, Hardman, Tim, Rossi, Jean-François
Publicado 2021

Open-label use of an aliphatic polyamine immunomodulator in patients hospitalized with COVID-19

por Efimov, Sergey V, Matsiyeuskaya, Natallia V, Boytsova, Olga V, Akhieva, Luydmila Yu, Kuntsevich, Elena V, Troshina, Anastasia A, Kvasova, Elena I, Tikhonov, Anton A, Khomyakova, Nadezhda F, Harrison, Francisco, Rossi, Jean-François, Hardman, Timothy C
Publicado 2022